🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent overview of #alopeciaareata from my friend and colleague Abigail Waldman, MD, a dermatologist and surgeon Brigham and Women’s Dermatology! youtu.be/rSp1VAm6CrE

Having a wonderful time National Alopecia Areata Foundation annual conference in Colorado. Incredible progress, remarkable stories. Lots of work left to do! #alopeciaareata

Loved every part of this The Topical Podcast podcast except for when 1) Kristina Liu talked about how much better Daniel Butler MD's hairline is than mine and 2) when I was reminded how much I miss getting the chance to see Dan in person on the regular. Hope you learn as much as I did!

We are excited to share a new article by Samantha Gregoire and Arash Mostaghimi on effective counseling of patients with hair loss, just published in JAAD as a special CME supplement! 1/

Meet #OLAPLEX’s first-ever scientific advisory board! 👩‍🔬👨‍🏫 🧬 The OLAPLEX Scientific Advisory board is a group of leading experts in dermatology. 🔬 Look forward to seeing more educational content while we work towards the goal of improving hair health through hair science!

And for you lazy folks out there here's the tweet for how to enter the raffle. Retweet this or send an email to us and 🤞you'll hear from us soon!

Take some time today to remember. newyorker.com/magazine/2002/…

Who knows what fame awaits you after you are on The Topical Podcast!

Purple bumps, inpatient Derm, and Oncoderm galore! 💜 No better way to start off a week than with a great Brigham and Women's Medicine Residents Med-Derm morning report, especially with Arash Mostaghimi! (will have to remember my bow tie for next time…)

JAKne? Systematic review &meta-analysis (25 studies, 10 839 pts), JAK inhibitor use was associated with an elevated odds of acne (OR 3-5 for UPA, TOFA, BARI, Deucra; but higher for abrocitinib (OR 13.5). Seen in Derm pts but hardly at all in Rheum pts bit.ly/3S8RP63

Thanks again to Arash Mostaghimi for joining our recent Analyst & Investor Day, in which we covered our multi-cytokine platform, our lead multi-cytokine asset, EQ101, and the aloppecia areata treatment lansdscape. If you weren't able yto join us, replay here: equilliumbio.com/investors/even…

Check out our systematic review in JAMA Dermatology on the potential role of nutraceuticals in the treatment of acne. Led by Ali Shields, we review data on zinc, vitamin D, vitamin B5, probiotics, green tea extract, and omega-3s, among other options. jamanetwork.com/journals/jamad…

Very much excited to help build on Joseph Merola, MD MMSc's efforts & expand dermatology trials Brigham and Women’s Dermatology. We're open for business! With over 50 dermatologists seeing 1000s of patients annually, we're equipped to recruit for even the most rare conditions. Contact me with ?s!

🚨 Out today in JAMA Dermatology! 🚨 Our illustrative analysis of potential spending on a new gene therapy, beremagene geperpavec (B-VEC), for people living with dystrophic epidermolysis bullosa. Co-authors: Aaron Kesselheim Arash Mostaghimi William Feldman jamanetwork.com/journals/jamad…

Published today! Spatial proteomics reveals JAK/STAT as a target for Toxic Epidermal Necrolysis, an often fatal skin reaction to common medication. We validated our findings in pre-clinical models & successfully treated the first patients worldwide.🧵⬇️ nature.com/articles/s4158…